Prognostic significance of left ventricular hypertrophy regression.
Agabiti-Rosei
E
E
Cattedra Semeiotica e Metodologia Medica, Universita' di Brescia, Italy. Agabiti@master cci.unibs.it
Muiesan
M L
ML
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D018572:Disease-Free Survival; D004452:Echocardiography; D004562:Electrocardiography; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology*; D011379:Prognosis; D015203:Reproducibility of Results; D012307:Risk Factors; D012680:Sensitivity and Specificity
D000959:Antihypertensive Agents